whi p154 has been researched along with 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, DL; Ball, DJ; Beals, CR; Beckius, GE; Blumenkopf, TA; Borie, DC; Brissette, WH; Brown, MF; Casavant, JM; Changelian, PS; Conklyn, MJ; Des Etages, SG; Doty, JL; Elliott, EA; Finco-Kent, D; Fisher, DA; Fisher, MB; Flanagan, ME; Gaweco, AS; Hayes, LS; Higgins, J; Hines, M; Holm, B; Johnson, KS; Kawabata, TT; Kent, CR; Koslov, ER; Kudlacz, EM; Larson, M; Lillie, BM; Littman, BH; Magna, HA; Magnuson, KS; Martin, WH; McCurdy, SP; Milici, AJ; Morris, RE; Moyer, JD; Munchhof, MJ; Nelms, LF; O'Shea, JJ; Paniagua, R; Perry, BD; Reitz, B; Rizzuti, BJ; Saltarelli, MJ; Sawyer, PS; Shang-Poa, C; Si, MS; Smith, JF; Strelevitz, TJ; Su, C; Subramanyam, C; Sun, J; Whipple, DA; Woodworth, TG; Yoon, K; Zagouras, P; Zhou, YJ | 1 |
| Klis, D; Liu, XP; Narla, RK; Uckun, FM | 1 |
| Ghosh, S; Liu, XP; Mahajan, S; Mao, C; Narla, RK; Sudbeck, EA; Uckun, FM | 1 |
| Aoyama, S; Hamada, H; Hirasawa, N; Linwong, W; Ohuchi, K; Saito, T | 1 |
| Kasprzycka, M; Marzec, M; Odum, N; Ptasznik, A; Wasik, MA; Wlodarski, P; Zhang, Q | 1 |
| Kankaanranta, H; Kärpänniemi, O; Korhonen, R; Moilanen, E; Nieminen, R; Sareila, O | 1 |
| Changelian, PS; Doty, JL; Flanagan, ME; Harris, TM; Kent, CR; Kudlacz, EM; Kuhn, CF; Magnuson, KS; Moshinsky, D; Munchhof, MJ; Perregaux, DG; Sawyer, PS; Sun, J; Whipple, DA | 1 |
| Bhavsar, SK; Bobbala, D; Gu, S; Lang, F | 1 |
| Bhavsar, SK; Hosseinzadeh, Z; Khairnar, V; Koepsell, H; Lang, F; Lang, KS; Lang, PA; Palmada, M; Sabolic, I; Sharma, P; Singh, Y; Zhang, S | 1 |
9 other study(ies) available for whi p154 and 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline
| Article | Year |
|---|---|
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.
Topics: Animals; Enzyme Inhibitors; Gene Expression Regulation; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Interleukin-2; Janus Kinase 3; Kidney Transplantation; Lymphocyte Activation; Lymphocyte Count; Lymphocyte Culture Test, Mixed; Lymphocyte Subsets; Macaca fascicularis; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Myocardium; Piperidines; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Transplantation, Heterotopic; Transplantation, Homologous; Tumor Cells, Cultured | 2003 |
Inhibition of human glioblastoma cell adhesion and invasion by 4-(4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131) and 4-(3'-bromo-4'-hydroxylphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P154).
Topics: Actins; Antineoplastic Agents; Cell Adhesion; Epidermal Growth Factor; Glioblastoma; Humans; Integrins; Neoplasm Invasiveness; Quinazolines; Tumor Cells, Cultured | 1998 |
Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents.
Topics: Antineoplastic Agents; Apoptosis; Binding Sites; Computer Simulation; Drug Design; Drug Evaluation, Preclinical; Humans; Janus Kinase 1; Janus Kinase 2; Janus Kinase 3; Leukemia; Models, Molecular; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Quinazolines; Substrate Specificity; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1999 |
Inhibition of the antigen-induced activation of rodent mast cells by putative Janus kinase 3 inhibitors WHI-P131 and WHI-P154 in a Janus kinase 3-independent manner.
Topics: Adaptor Proteins, Signal Transducing; Animals; Cell Cycle Proteins; Cell Degranulation; Cell Line, Tumor; Dinitrophenols; Hexosaminidases; Immunoglobulin E; Janus Kinase 3; Mast Cells; Mice; Mice, Knockout; Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-fyn; Proto-Oncogene Proteins c-vav; Quinazolines; Rats; Serum Albumin; src-Family Kinases | 2005 |
Inhibition of ALK enzymatic activity in T-cell lymphoma cells induces apoptosis and suppresses proliferation and STAT3 phosphorylation independently of Jak3.
Topics: Anaplastic Lymphoma Kinase; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Janus Kinase 3; Lymphoma, T-Cell; Phosphorylation; Protein-Tyrosine Kinases; Quinazolines; Receptor Protein-Tyrosine Kinases; STAT3 Transcription Factor | 2005 |
Janus kinase 3 inhibitor WHI-P154 in macrophages activated by bacterial endotoxin: differential effects on the expression of iNOS, COX-2 and TNF-alpha.
Topics: Cell Line; Cyclooxygenase 2; Down-Regulation; Humans; Interferon-gamma; Janus Kinase 3; Lipopolysaccharides; Macrophage Activation; Macrophages; Nitric Oxide; Nitric Oxide Synthase Type II; Protein Kinase Inhibitors; Quinazolines; STAT1 Transcription Factor; Tumor Necrosis Factor-alpha | 2008 |
The specificity of JAK3 kinase inhibitors.
Topics: Arthritis, Rheumatoid; Clinical Trials as Topic; Enzyme Inhibitors; Graft Rejection; Humans; Janus Kinase 3; Kinetics; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Quinazolines | 2008 |
Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death.
Topics: Adenosine Triphosphate; Animals; Annexin A5; Cell Death; Cell Size; Erythrocyte Count; Erythrocytes; Female; Flow Cytometry; Gene Deletion; Glucose; Humans; Immunohistochemistry; Janus Kinase 3; Male; Mice; Mice, Knockout; Microscopy, Confocal; Phosphatidylserines; Phosphorylation; Protein Kinase Inhibitors; Quinazolines | 2011 |
Expression of JAK3 Sensitive Na+ Coupled Glucose Carrier SGLT1 in Activated Cytotoxic T Lymphocytes.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Biological Transport; Brefeldin A; Caco-2 Cells; Deoxyglucose; Gene Expression Regulation; Glucose; Humans; Janus Kinase 3; Jurkat Cells; Lymphocyte Activation; Mice; Oocytes; Patch-Clamp Techniques; Phlorhizin; Primary Cell Culture; Quinazolines; Signal Transduction; Sodium-Glucose Transporter 1; Spleen; T-Lymphocytes, Cytotoxic; Transgenes; Xenopus laevis | 2016 |